![](/img/cover-not-exists.png)
A Phase II Trial of Salirasib in Patients with Lung Adenocarcinomas with KRAS Mutations
Riely, Gregory J., Johnson, Melissa L., Medina, Chanoa, Rizvi, Naiyer A., Miller, Vincent A., Kris, Mark G., Pietanza, M. Catherine, Azzoli, Christopher G., Krug, Lee M., Pao, William, Ginsberg, MicheVolume:
6
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/JTO.0b013e318223c099
Date:
August, 2011
File:
PDF, 143 KB
english, 2011